Institute of Gerontology
About Institute of Gerontology
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Boehringer Ingelheim
3
Kowa Research Institute, Inc.
2
Pfizer
2
Akorn, Inc.
1
Anthera Pharmaceuticals
1
Dr. Reddy's Laboratories Limited
1
Clinical Trials at Institute of Gerontology
During the past decade, Institute of Gerontology conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 8 clinical trials were completed, i.e. on
average, 160% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 6 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Multi-Center Trial to Compare Three Doses of Meloxicam and Placebo in Patients With Rheumatoid Arthritis
2002-06-01
2003-07-01
Completed
1,000
PLASMA Trial: A Dose-Response Study of A-002 In Subjects With Stable Coronary Artery Disease
2007-04-01
2007-09-01
Completed
400
Long-Term Analgesic Efficacy And Safety Of Tanezumab Alone Or In Combination With Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Versus NSAIDs Alone In Patients With Osteoarthritis Of The Knee Or Hip
2009-02-12
2011-01-12
Terminated
2,720
Analgesic Efficacy And Safety of Tanezumab Added On To Diclofenac SR In Patients With Osteoarthritis Of The Knee Or Hip
2009-08-11
2010-11-24
Terminated
607
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
2015-01-26
2016-10-18
Completed
645
Comparative Pharmacokinetic, Pharmacodynamic, Safety and Efficacy Study of Three Anti-CD20 Monoclonal Antibodies in Patients With Moderate to Severe Rheumatoid Arthritis
2014-11-01
2017-10-05
Completed
276
Long-term Assessment of Safety and Efficacy of BI 695501 in Patients With Rheumatoid Arthritis
2016-01-22
2017-11-01
Completed
430
Bioequivalence Study With Clinical Endpoint for Diclofenac Sodium Topical Gel 1%
2015-06-01
2016-06-01
Completed
934
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Institute of Gerontology" #1 sponsor was "Boehringer Ingelheim" with 3 trials, followed by "Kowa Research Institute, Inc." with 2 trials
sponsored, "Pfizer" with 2 trials sponsored, "Akorn, Inc." with 1 trials sponsored and "Anthera Pharmaceuticals"
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
Clinical Trials Conditions at Institute of Gerontology
According to Clinical.Site data, the most researched conditions in "Institute of Gerontology" are
"Arthritis, Rheumatoid" (3 trials), "Osteoarthritis" (2 trials), "Severe Hypertriglyceridemia" (2 trials), "Arthritis" (1 trials) and "Coronary Artery Disease (CAD)" (1 trials). Many other conditions were trialed in "Institute of Gerontology" in a lesser frequency.
Clinical Trials Intervention Types at Institute of Gerontology
Most popular intervention types in "Institute of Gerontology" are "Drug" (9 trials), "Biological" (3 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "BI 695501" (2 trials), "Fenofibrate" (2 trials), "K-877" (2 trials), "Placebo (for K-877)" (2 trials) and "tanezumab" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Institute of Gerontology
The vast majority of trials in "Institute of Gerontology" are
10 trials for "All" genders.
Clinical Trials Status at Institute of Gerontology
Currently, there are NaN active trials in "Institute of Gerontology".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 8 completed trials in Institute of Gerontology,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Institute of Gerontology, 1 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 8 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".